Act Two Investors LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Act Two Investors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 45.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,357 shares of the healthcare conglomerate's stock after selling 29,319 shares during the period. UnitedHealth Group accounts for about 3.5% of Act Two Investors LLC's holdings, making the stock its 12th biggest position. Act Two Investors LLC's holdings in UnitedHealth Group were worth $17,886,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Western Pacific Wealth Management LP increased its stake in UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after purchasing an additional 19 shares during the period. MCF Advisors LLC increased its holdings in UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after buying an additional 20 shares in the last quarter. Axiom Financial Strategies LLC lifted its holdings in shares of UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after buying an additional 20 shares during the period. Richwood Investment Advisors LLC increased its holdings in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after buying an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after buying an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Remove Ads

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research reports. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Truist Financial increased their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the company a "buy" rating in a research report on Friday. Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Twenty-one equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of "Buy" and an average price target of $632.85.

UnitedHealth Group Price Performance

NYSE UNH traded down $13.24 on Monday, hitting $586.23. The company had a trading volume of 4,749,319 shares, compared to its average volume of 4,346,438. The company's fifty day moving average price is $512.87 and its 200-day moving average price is $541.80. UnitedHealth Group Incorporated has a 12-month low of $438.50 and a 12-month high of $630.73. The company has a market capitalization of $536.23 billion, a PE ratio of 37.82, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The business's quarterly revenue was up 6.8% compared to the same quarter last year. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.43%. UnitedHealth Group's dividend payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.